Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer

Femme et Homme

| Pays :
Japan
| Organes :
| Spécialités :

Extrait

The purpose of this study is to evaluate the safety and time to progression of HLA-A*2402 restricted epitope peptides URLC10, TTK, and KOC1, emulsified with Montanide ISA 51.

Critère d'inclusion

Esophageal Cancer

Liens

nct
ictrp